Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAS 41004 in Plaque Psoriasis
NCT01360944Phase 2Completed
- Sponsor
- Almirall
- Start
- May 2011
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LAS41004 IMP5 in plaque psoriasis, sponsored by Almirall. Started May 2011; status: completed.
02
Drugs
LAS41004 IMP5
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01360944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01360944.